Inovio Pharmaceuticals, Inc. (INO)
NASDAQ · Healthcare
Inovio Pharmaceuticals, Inc. Revenue 2009–2025
Inovio Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Inovio Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Inovio Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 65343, a 86.64% decrease year-over-year.
- Inovio Pharmaceuticals, Inc. annual revenue for 2025 was 65343, a 69.99% decrease from 2024.
- Inovio Pharmaceuticals, Inc. annual revenue for 2024 was 217756, a 73.83% decrease from 2023.
- Inovio Pharmaceuticals, Inc. annual revenue for 2023 was 832010, a 91.89% decrease from 2022.
- Inovio Pharmaceuticals, Inc. annual revenue for 2022 was 10.3 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Inovio Pharmaceuticals, Inc. Market Cap — FAQ
Inovio Pharmaceuticals, Inc. (INO) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INO's market cap history?
The chart and table above show Inovio Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.